Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$449.00
|
|
Provider: GlobalData
|
$334.00
|
|
Provider: GlobalData
|
$75.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Stentys SAS Announces Initial Public Offering On Euronext Paris Stock Exchange
Stentys SAS announced that it will be trading for the first time on Euronext Paris stock exchange on October 25, 2010 by issuing 1,893,939 shares, costing EUR 12 per share, total amounting to EUR 22.7 million. The settlement date is October 27, 2010 and the date limited for excercing the option of allocation is fixed for November 19, 2010. The lead managers are Societe Generale and Corporate & Investment Banking.
Latest Developments for Stentys SA
- Stentys SA Announces Results of APPOSITION III Clinical Study
- Stentys SA Launches Private Placement Of Up To 10% Of Capital
- Stentys SA Announces Positive Interim Results of International Clinical Study of 600 Heart Attack Patients
- Stentys SA Announces Results of APPOSITION I clinical study of Its Self-Apposing Stent to Treat Acute Myocardial Infarction
Latest Key Developments in Medical Equipment / Supplies / Distribution
- Share this
- Link this
- Digg this
Follow Reuters